Cheryl Marriott

3.8k total citations
5 papers, 264 citations indexed

About

Cheryl Marriott is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Cheryl Marriott has authored 5 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Cheryl Marriott's work include Angiogenesis and VEGF in Cancer (2 papers), Cancer Mechanisms and Therapy (2 papers) and Ethics in Clinical Research (1 paper). Cheryl Marriott is often cited by papers focused on Angiogenesis and VEGF in Cancer (2 papers), Cancer Mechanisms and Therapy (2 papers) and Ethics in Clinical Research (1 paper). Cheryl Marriott collaborates with scholars based in United Kingdom, France and United States. Cheryl Marriott's co-authors include Sing Yu Moorcraft, Sheela Rao, Ian Chau, Naureen Starling, Clare Peckitt, David Cunningham, David Watkins, Sharianne G. Louie, Natasha Aziz and Johann S. de Bono and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Trials.

In The Last Decade

Cheryl Marriott

5 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl Marriott United Kingdom 3 99 97 55 48 41 5 264
Saira Khan United States 11 57 0.6× 37 0.4× 100 1.8× 102 2.1× 21 0.5× 43 325
Leigh Boehmer United States 9 47 0.5× 53 0.5× 96 1.7× 64 1.3× 24 0.6× 42 253
Vida Almario Passero United States 7 41 0.4× 50 0.5× 78 1.4× 32 0.7× 38 0.9× 24 228
Juan Javier‐Desloges United States 11 49 0.5× 62 0.6× 74 1.3× 112 2.3× 46 1.1× 39 271
Neil T. Phippen United States 11 68 0.7× 47 0.5× 85 1.5× 34 0.7× 17 0.4× 30 286
Courtney D. Storm United States 7 87 0.9× 74 0.8× 71 1.3× 19 0.4× 30 0.7× 9 434
Deanna Cross United States 10 48 0.5× 48 0.5× 74 1.3× 29 0.6× 19 0.5× 24 288
Margaret M. McGovern United States 9 39 0.4× 88 0.9× 57 1.0× 21 0.4× 22 0.5× 13 344
Deep Shah United States 11 77 0.8× 34 0.4× 113 2.1× 23 0.5× 16 0.4× 20 313
Joan Basiuk Canada 8 68 0.7× 35 0.4× 38 0.7× 170 3.5× 31 0.8× 11 232

Countries citing papers authored by Cheryl Marriott

Since Specialization
Citations

This map shows the geographic impact of Cheryl Marriott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Marriott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Marriott more than expected).

Fields of papers citing papers by Cheryl Marriott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Marriott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Marriott. The network helps show where Cheryl Marriott may publish in the future.

Co-authorship network of co-authors of Cheryl Marriott

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Marriott. A scholar is included among the top collaborators of Cheryl Marriott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Marriott. Cheryl Marriott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Woodroffe, Roșie, Peter N. M. Brotherton, Christl A. Donnelly, et al.. (2024). Farmer‐led badger vaccination in Cornwall: Epidemiological patterns and social perspectives. People and Nature. 6(5). 1960–1973. 3 indexed citations
2.
Moorcraft, Sing Yu, Cheryl Marriott, Clare Peckitt, et al.. (2016). Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey. Trials. 17(1). 17–17. 140 indexed citations
3.
Sarker, Debashis, R. Molife, T. R. J. Evans, et al.. (2008). A Phase I Pharmacokinetic and Pharmacodynamic Study of TKI258, an Oral, Multitargeted Receptor Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors. Clinical Cancer Research. 14(7). 2075–2081. 117 indexed citations
4.
Sarker, Debashis, Jonathan J. Evans, R. Molife, et al.. (2006). A phase 1, pharmacokinetic (PK) and pharmacodynamic (PD) study of CHIR-258, a novel oral multiple receptor tyrosine kinase (RTK) inhibitor. Journal of Clinical Oncology. 24(18_suppl). 3043–3043. 2 indexed citations
5.
Sarker, Debashis, Jonathan J. Evans, I. Judson, et al.. (2005). CHIR-258: first-in-human phase 1 dose escalating trial of an oral, selectively targeted tyrosine kinase inhibitor in patients with solid tumors. Journal of Clinical Oncology. 23(16_suppl). 3044–3044. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026